Quinoxalinylethylpyridylthioureas (QXPTs) as Potent Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors. Further SAR Studies and Identification of a Novel Orally Bioavailable Hydrazine-Based Antiviral AgentGiuseppe Campiani, Silvio Caccia, Silvia Armaroli et al.|Journal of Medicinal Chemistry|2001Cited by 94
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral ActivityCaterina Fattorusso, Giuseppe Campiani, Giovanni Greco et al.|Journal of Medicinal Chemistry|2005Cited by 45
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Giuseppe Campiani, Rosaria Benedetti et al.|ACS Pharmacology & Translational Science|2024Cited by 7